By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PARI Pharma 

Steinerstrasse 15A

Munich    D-81369  Germany
Phone: 49-89-742-84669 Fax: 49-89-742-84650


SEARCH JOBS


Industry
Pharmaceutical






Company News
PARI Pharma's Altera Delivers Gilead Sciences, Inc. (GILD)'s Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 6/21/2010 11:08:20 AM
PARI Pharma Enrolls First Patient in Phase 2b Study of L-CsA 2/11/2010 10:29:56 AM
PARI Pharma's Altera Delivers Gilead Sciences, Inc. (GILD)'s Cayston, Approved by European Commission to Treat Cystic Fibrosis 9/24/2009 8:45:06 AM
Mpex Pharmaceuticals, Inc. Reports Positive Phase II Results with Aeroquin, Delivered by PARI Pharma's eFlow Technology 9/15/2009 7:59:58 AM
PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans 6/3/2009 8:24:14 AM
PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 5/21/2009 10:48:34 AM
PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 5/8/2009 11:28:44 AM
PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 11/10/2008 11:55:17 AM
PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 10/7/2008 9:22:11 AM
PARI Pharma's eFlow Delivers Alnylam Pharmaceuticals (ALNY) RNAi Therapeutic in Phase II Study 4/17/2008 10:27:04 AM
12
//-->